Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication ofHelicobacter pylori
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication ofHelicobacter pylori
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 40, Issue 2, Pages 171-177
Publisher
Wiley
Online
2014-05-26
DOI
10.1111/apt.12808
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy
- (2013) Min Soo Kim et al. BMC GASTROENTEROLOGY
- Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment ofHelicobacter pyloriInfection
- (2013) Marino Venerito et al. DIGESTION
- Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
- (2013) J. P. Gisbert et al. DIGESTIVE DISEASES AND SCIENCES
- Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies
- (2013) Michael Selgrad et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Helicobacter pylori Infection Is Strongly Associated With Gastric and Duodenal Ulcers in a Large Prospective Study
- (2012) Ben Schöttker et al. Clinical Gastroenterology and Hepatology
- Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report
- (2012) Peter Malfertheiner et al. GUT
- Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption
- (2012) Francis Megraud et al. GUT
- Greater Than 95% Success with 14-day Bismuth Quadruple Anti-Helicobacter pyloriTherapy: A Pilot Study in US Hispanics
- (2012) Cesar O. Salazar et al. HELICOBACTER
- Predicting Helicobacter pylori Eradication
- (2012) Angelo Zullo et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Recent Insights into Antibiotic Resistance inHelicobacter pyloriEradication
- (2012) Wenming Wu et al. Gastroenterology Research and Practice
- Twice-a-Day Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Trial of 10 and 14 Days
- (2011) Maria Pina Dore et al. HELICOBACTER
- Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
- (2011) Peter Malfertheiner et al. LANCET
- Helicobacter pylori treatment in the era of increasing antibiotic resistance
- (2010) D. Y. Graham et al. GUT
- Bismuth-Containing Quadruple Therapy as Second-Line Treatment forHelicobacter pyloriInfection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate in Korea
- (2010) Byoung Hwan Lee et al. HELICOBACTER
- Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability
- (2009) Jay Luther et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection
- (2009) K Ming Fock et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
- (2008) Alexander C Ford et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More